New vaccine support (NVS) for ROTA

GAVI’s support for new vaccines presents an opportunity for countries to not only implement vaccines that protect against diseases causing substantial morbidity and/or mortality, but also to build upon the vaccine investments in order to increase immunisation coverage rates, and strengthen routine immunisation services and primary health care systems. Rotavirus vaccine protects children against rotavirus disease and the severe and deadly diarrhoea that it causes in children. WHO recommends that rotavirus vaccination be included in all national immunization programmes, and the use of rotavirus vaccines should be part of a comprehensive strategy to control diarrhoeal diseases. Two oral rotavirus vaccines are currently available for routine infant immunisation with GAVI support: a two-dose schedule and the three-dose schedule vaccine.

Project ID
47122-15-LBR-13B-X
Activity status
3 - Completion
Aid type
B02 - Core contributions to multilateral institutions
% to Liberia
100.00

Organisations

Funding
The Global Alliance for Vaccination and Immunisation
Extending
World Health Organisation - core voluntary contributions account (for technical assitance)
Accountable
Federal States & Local Governments
Implementing
Federal States & Local Governments
Extending
United Nations Childrens Fund

Disbursements by fiscal year, quarter

Fiscal year Fiscal quarter Value (USD) Liberia Value (USD)
2017 Q1 0.00 0.00
2016 Q4 -26,867.00 -26,867.00
2015 Q1 992,941.00 992,941.00
2014 Q4 -502,761.00 -502,761.00
2014 Q3 520,761.00 520,761.00

Commitments by fiscal year, quarter

Fiscal year Fiscal quarter Value (USD) Liberia Value (USD)
2017 Q2 -26,867.00 -26,867.00
2015 Q2 -7,059.00 -7,059.00
2015 Q1 76,500.00 76,500.00
2014 Q2 -8,000.00 -8,000.00
2013 Q3 949,500.00 949,500.00

MTEF projections by fiscal year

Fiscal year Value (USD) Liberia Value (USD)
2015 474,750.00 474,750.00
2014 474,750.00 474,750.00

CRS code %
Infectious disease control (12250) 100.0